danny.kv pharmaceuticals has spent more than 170 million on evamist.one would think they are very keen to make it work.it looks like the use of evamist is trending up but not as quickly as anticipated
- Forums
- ASX - By Stock
- bioshares on evamist and kv
ACR
acrux limited
Add to My Watchlist
0.00%
!
1.6¢

danny.kv pharmaceuticals has spent more than 170 million on...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.524M |
Open | High | Low | Value | Volume |
1.5¢ | 1.6¢ | 1.5¢ | $9.887K | 624.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 6355 | 1.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.7¢ | 20000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 6355 | 0.016 |
4 | 559314 | 0.015 |
3 | 420000 | 0.014 |
2 | 397000 | 0.013 |
1 | 80000 | 0.012 |
Price($) | Vol. | No. |
---|---|---|
0.017 | 20000 | 1 |
0.018 | 252359 | 2 |
0.019 | 677115 | 3 |
0.020 | 50000 | 1 |
0.021 | 203466 | 1 |
Last trade - 15.00pm 26/06/2025 (20 minute delay) ? |
Featured News
ACR (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online